Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Cancer Res ; 3(11): 627-34, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16317088

RESUMO

The Chk2 kinase is a tumor suppressor and key component of the DNA damage checkpoint response that encompasses cell cycle arrest, apoptosis, and DNA repair. It has also been shown to have a role in replicative senescence resulting from dysfunctional telomeres. Some of these functions are at least partially exerted through activation of the p53 transcription factor. High-level expression of virally transduced Chk2 in A549 human lung carcinoma cells led to arrested proliferation, apoptosis, and senescence. These were accompanied by various molecular events, including p21(Waf1/Cip1) (p21) transcriptional induction, consistent with p53 activation. However, Chk2-dependent senescence and p21 transcriptional induction also occurred in p53-defective SK-BR-3 (breast carcinoma) and HaCaT (immortalized keratinocyte) cells. Small interfering RNA-mediated knockdown of p21 in p53-defective cells expressing Chk2 resulted in a decrease in senescent cells. These results revealed a p53-independent role for Chk2 in p21 induction and senescence that may contribute to tumor suppression and genotoxic treatment outcome.


Assuntos
Inibidor de Quinase Dependente de Ciclina p21/genética , Proteínas Serina-Treonina Quinases/genética , Proteína Supressora de Tumor p53/metabolismo , Apoptose/fisiologia , Neoplasias da Mama , Divisão Celular/fisiologia , Linhagem Celular Transformada , Linhagem Celular Tumoral , Senescência Celular/fisiologia , Quinase do Ponto de Checagem 2 , Regulação Neoplásica da Expressão Gênica , Humanos , Queratinócitos/citologia , Neoplasias Pulmonares , RNA Interferente Pequeno , Retroviridae/genética , Transdução Genética
2.
FEBS Lett ; 566(1-3): 60-4, 2004 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-15147869

RESUMO

Glycogen synthase kinase-3beta (GSK-3beta) is a key component of several signaling pathways. We found that a short variant of 'TNF-like weak inducer of apoptosis' (shortTWEAK) formed a complex with GSK-3beta in a yeast two-hybrid system. We demonstrate that shortTWEAK and GSK-3beta colocalize in the nucleus of human neuroblastoma cells. We also show that TWEAK is internalized in different cell lines and that it translocates to the nucleus. This event causes the degradation of IkappaBalpha, the nuclear translocation of both GSK-3beta and p65, and the induction of NF-kappaB-driven gene expression. We demonstrate that the induction of IL-8 expression by TWEAK can be counteracted by LiCl. Taken together, these data suggest that GSK-3beta plays an important role in the signal transduction pathway between TWEAK and NF-kappaB.


Assuntos
Proteínas de Transporte/metabolismo , Quinase 3 da Glicogênio Sintase/metabolismo , NF-kappa B/metabolismo , Animais , Proteínas Reguladoras de Apoptose , Proteínas de Transporte/genética , Linhagem Celular , Núcleo Celular/metabolismo , Citocina TWEAK , Inibidores Enzimáticos/farmacologia , Expressão Gênica , Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Quinase 3 da Glicogênio Sintase/genética , Quinase 3 da Glicogênio Sintase/farmacologia , Glicogênio Sintase Quinase 3 beta , Humanos , Interleucina-8/genética , Interleucina-8/metabolismo , Células Jurkat , Cloreto de Lítio/farmacologia , Camundongos , Regiões Promotoras Genéticas/efeitos dos fármacos , Regiões Promotoras Genéticas/genética , Transporte Proteico , Proteínas Recombinantes/antagonistas & inibidores , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia , Fator de Transcrição RelA , Fator de Necrose Tumoral alfa/farmacologia , Fatores de Necrose Tumoral , Técnicas do Sistema de Duplo-Híbrido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA